AARD compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name

AARDAardvark Therapeutics, Inc.

Mkt capRevenueRevenue

LLYELI Lilly & Co

Mkt capRevenueRevenue

Compare

AARDAardvark Therapeutics, Inc.

LLYELI Lilly & Co

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

AARDAardvark Therapeutics, Inc.

1.25▲+1.64%· post 1.23· delayed

Mkt cap$26.9MRevenue—Revenue—

LLYELI Lilly & Co

1,417.89▲+0.60%· post 1,417.73· delayed

After hoursNov 4 '26delayed

Mkt cap$1.3TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

Compare

After hoursNov 4 '26delayed

AARDAardvark Therapeutics, Inc.

LLYELI Lilly & Co

1.25▲+1.64%post 1.23delayed

Price

1,417.89▲+0.60%post 1,417.73delayed

$26.9M

Mkt cap

$1.3T

—

Revenue

$24.4BQ3 FY26

—

Revenue

$65.2BFY25

AARD1.25▲+1.64%vsLLY1,417.89▲+0.60%After hoursNov 4 '26delayed

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

AARD: latest quarter not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only AARD 0

None

Shared 0

No disclosed counterparties: AARD.

Only LLY 29

MCKMcKessoncustomer

CAHCardinal Healthcustomer

VEEVVeeva Systemssupplier

UTHRUnited Therapeuticscustomer

25 more · LLY chain ›

Role chip = supplier or customerSource: SEC EDGAR

Price

rebased to 0%

AARD, solidLLY, dashed